From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries

Abstract

BackgroundUnderstanding the implementation of 2013 World Health Organization (WHO) consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection at the facility level provides important lessons for the roll-out of future HIV policies.MethodsA national policy review was conducted in six sub-Saharan African countries to map the inclusion of the 2013 WHO HIV treatment recommendations. Twenty indicators of policy adoption were selected to measure ART access (n = 12) and retention (n = 8). Two sequential cross-sectional surveys were conducted in facilities between 2013/2015 (round 1) and 2015/2016 (round 2) from ten health and demographic surveillance sites in Kenya, Malawi, South Africa, Tanzania, Uganda and Zimbabwe. Using standardised questionnaires, facility managers were interviewed. Descriptive analyses were used to assess the change in the proportion of facilities that implemented these policy indicators between rounds.ResultsAlthough, expansion of ART access was explicitly stated in all countries’ policies, most lacked policies that enhanced retention. Overall, 145 facilities were included in both rounds. The proportion of facilities that initiated ART at CD4 counts of 500 or less cells/μL increased between round 1 and 2 from 12 to 68%, and facilities initiating patients on 2013 WHO recommended ART regimen increased from 42 to 87%. There were no changes in the proportion of facilities reporting stock-outs of first-line ART in the past year (18 to 11%) nor in the provision of three-month supply of ART (43 to 38%). None of the facilities provided community-based ART delivery.ConclusionThe increase in ART initiation CD4 threshold in most countries, and substantial improvements made in the provision of WHO recommended first-line ART regimens demonstrates that rapid adoption of WHO recommendations is possible. However, improved logistics and resources and/or changes in policy are required to further minimise ART stock-outs and allow lay cadres to dispense ART in the community. Increased efforts are needed to offer longer durations between clinic visits, a strategy purported to improve retention. These changes will be important as countries move to implement the revised 2015 WHO guidelines to initiate all HIV positive people onto ART regardless of their immune status.Electronic supplementary materialThe online version of this article (10.1186/s12913-017-2678-1) contains supplementary material, which is available to authorized users.

A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe

“…However, in general, our findings for east Zimbabwe fit a wider pattern of substantial overall progress in adoption and implementation of WHO recommendations on HIV testing and treatment services, albeit with some important gaps remaining (e.g. services for high-risk groups) [ 56 ].…”

Implementing prevention policies for mother-to-child transmission of HIV in rural Malawi, South Africa and United Republic of Tanzania, 2013–2016

“…We also need data about implementation gaps at the facility level and the consequences for managing supplies of drugs and diagnostic tests. Although previous research has investigated HIV policy adoption and implementation in sub-Saharan Africa, 12,[15][16][17][18][19] few studies have documented implementation of PMTCT policies, especially after implementation of Option B+, and in rural settings. This paper used data from policy reviews and health-facility surveys conducted with health workers between 2013 and 2016 in five health and demographic surveillance system sites in rural Malawi, South Africa and the United Republic of Tanzania.…”

Nurse-led pre-exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial

“…3 Countries in Africa and the UK have expanded the role of nurses in HIV care, including prescribing antiretroviral therapy (ART) for treatment and PrEP, to overcome doctor shortages and other resource limitations. [4][5][6][7][8] There are few published studies on nurse-led models of care for HIV, despite WHO recommendations on task shifting from 2008 9 . However, the available evidence from Africa shows that shifting HIV care from doctors to adequately trained and supported nurses does not decrease the quality of care.…”